[Semiconductor Manufacturing International Corporation Dr. Gao Yonggang Executive Director, Chief Financial Officer and Joint Company Secretary]
[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: September 30, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained h]
[Recon Technology Reports Fiscal 2018 First Quarter and First Three Months Financial Results Highlighted by Higher Revenues and Operating Margins BEIJING, November 15, 2017 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON), ("Recon" or the "Company"), a China-based independent solutions integrato]
[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: September 30, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained h]
[Recon Technology Reports Fiscal 2018 First Quarter and First Three Months Financial Results Highlighted by Higher Revenues and Operating Margins BEIJING, November 15, 2017 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON), ("Recon" or the "Company"), a China-based independent solutions integrato]
[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]
[China Green Agriculture Reports First Fiscal Quarter 2018’s Financial Results, Meets Guidance, and Confirms Full Year Guidance XI’AN, China, Nov 15, 2017 /GLOBE NEWSWIRE / -- China Green Agriculture, Inc. (NYSE: CGA; “China Green Agriculture” or the “Company”), a company which mainly produces and di]
[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]
